SCHEMBL1709627

SCHEMBL1709627

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(COC(=O)NC2CC2)n(C)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.46
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
TSHR P16473 1/20 0.35
SCN1A P35498 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN3A Q9NY46 1/20 0.35
DPP4 P27487 6/20 0.35
DPP7 Q9UHL4 6/20 0.35
KCNH2 Q12809 4/20 0.34
JAK2 O60674 1/20 0.34
JAK1 P23458 1/20 0.34
TYK2 P29597 1/20 0.34
CCR5 P51681 1/20 0.33
CTSL P07711 1/20 0.33
CTSB P07858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1709626 0.97 GHSR (0.45) GHSRHDAC1HDAC6ALDH1A1GAA
SCHEMBL1709629 0.97 GHSR (0.45) GHSRHDAC1HDAC6ALDH1A1GAA
SCHEMBL1709564 0.96 GHSR (0.44) GHSRHDAC1HDAC6ALDH1A1TSHR
SCHEMBL10121986 0.89 GHSR (0.48) GHSRHDAC1HDAC6GAASCN1A
SCHEMBL10121652 0.87 GHSR (0.47) GHSRHDAC1HDAC6ALDH1A1GAA
SCHEMBL10121714 0.87 GHSR (0.47) GHSRHDAC1HDAC6GAASCN1A
SCHEMBL10121725 0.87 GHSR (0.49) GHSRHDAC1HDAC6GAASCN1A
SCHEMBL1709692 0.86 GHSR (0.48) GHSRHDAC1HDAC6GAASCN1A
SCHEMBL10122225 0.86 GHSR (0.44) GHSRHDAC1HDAC6TSHRSCN1A
SCHEMBL10121783 0.86 GHSR (0.45) GHSRALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF ELIXIR PHARMACEUTICALS, INC. 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF GHSR, GHRHR, STS GHSR 1/4885HDAC1 803/4885HDAC6 186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.